Understanding Your Blood Work: What Your Doctor Might Not Explain

The results arrive in the patient portal, sometimes before the doctor has had a chance to review them. A column of numbers, a reference range beside each one, and a scattering of colored flags — H for high, L for low — marking the values that fall outside the normal window. At the bottom, perhaps, a brief note: "Results reviewed. Follow up in one year."

For many patients, this is where the story ends. The numbers are there, technically available, but effectively inaccessible — meaningful to someone with medical training, opaque to almost everyone else. Questions form and go unasked. The portal is closed. Life continues.

This is a problem, and not a trivial one. Blood work is one of the most powerful tools in medicine — a window into what the body is doing that can detect disease in its early stages, track the progression of known conditions, identify medication side effects, and flag developing problems before they become serious. But that value is only realized when patients understand what they're looking at well enough to ask the right questions.

This guide is not a substitute for a physician's interpretation. Blood test results always need clinical context — a number that is alarming in one patient may be entirely appropriate in another, and a number that appears normal can still be meaningful when viewed in the context of a patient's history and trends over time. What this guide provides is a foundation: a plain-language explanation of the most common blood tests, what they measure, and what to pay attention to when the results arrive.

The Complete Blood Count (CBC)

The complete blood count is one of the most commonly ordered blood tests in medicine, and it is often the starting point for evaluating a patient who isn't feeling well or who is undergoing routine screening.

The CBC measures the three main types of cells in the blood: red blood cells, white blood cells, and platelets. Each tells a different part of the story.

Red blood cells carry oxygen from the lungs to the rest of the body. When red blood cell counts are low — or when hemoglobin, the protein that carries oxygen within red blood cells, is below normal — the result is anemia. Anemia has many causes, including iron deficiency, vitamin B12 or folate deficiency, chronic disease, and blood loss. Symptoms include fatigue, weakness, shortness of breath, and pallor — symptoms that are easy to attribute to other causes without a blood test to clarify.

White blood cells are the immune system's primary workforce. An elevated white blood cell count can signal infection, inflammation, or in some cases, blood disorders including leukemia. A low count can indicate that the immune system is compromised, either from disease or as a side effect of certain medications. The CBC typically breaks down white blood cells into their component types — neutrophils, lymphocytes, monocytes, eosinophils, and basophils — and the pattern of elevation or reduction across these subtypes provides important diagnostic information.

Platelets are the cells responsible for blood clotting. A low platelet count can lead to excessive bleeding; a very high count can indicate inflammation or, rarely, a bone marrow disorder. Platelet counts that are persistently abnormal in either direction deserve follow-up.

What patients should know: a CBC provides a snapshot, not a diagnosis. A mildly abnormal result may reflect nothing more than the timing of the draw — white blood cell counts, for example, can fluctuate with physical stress, minor infection, or even vigorous exercise. Trends over time are often more meaningful than any single result.

The Basic and Comprehensive Metabolic Panel

The metabolic panel — either the basic version (BMP) or the more extensive comprehensive version (CMP) — evaluates the body's chemical balance and the function of key organs, primarily the kidneys and liver.

Kidney function is assessed through two markers: creatinine and blood urea nitrogen, commonly referred to as BUN. Both are waste products that the kidneys filter from the blood. When kidney function is impaired, these values rise. Elevated creatinine and BUN can indicate acute kidney injury — which may be caused by dehydration, medication effects, or a sudden illness — or chronic kidney disease developing over time.

Electrolytes — sodium, potassium, chloride, and bicarbonate — are also measured in the metabolic panel. These are the salts and minerals that regulate fluid balance, nerve function, and muscle activity, including the heart. Abnormal electrolyte levels can result from medications, particularly diuretics, from kidney problems, from endocrine disorders, or from significant changes in diet or fluid intake.

Blood glucose is included in the metabolic panel and provides a snapshot of blood sugar at the time of the draw. This is distinct from the hemoglobin A1c, which reflects average blood sugar over several months and is the more useful marker for evaluating diabetes control.

What patients should know: the metabolic panel is where medication side effects often show up. A patient taking a new blood pressure medication, a diuretic, or certain antibiotics may see changes in kidney markers or electrolytes that reflect how the medication is affecting the body. Reviewing these results in the context of the medication list is essential — and this is a context that is sometimes missed when results are reviewed quickly in a busy clinical setting.

Liver Function Tests

The liver function panel measures a set of enzymes and proteins that reflect how well the liver is working and whether it is under stress.

The key markers are the aminotransferases — AST and ALT — which are enzymes released when liver cells are damaged or inflamed. Elevated AST and ALT can indicate a range of conditions, from relatively benign causes like vigorous exercise or fatty liver disease, to more serious ones including hepatitis, medication toxicity, or excessive alcohol intake. Alkaline phosphatase, another enzyme measured in this panel, can reflect liver disease but also bone disorders — its interpretation depends on the clinical context.

Bilirubin is a breakdown product of red blood cells processed by the liver. Elevated bilirubin can cause jaundice — the yellowing of the skin and eyes — and may indicate liver disease, bile duct obstruction, or a problem with red blood cell breakdown. Albumin and total protein reflect the liver's ability to produce proteins, a function that is impaired in advanced liver disease.

What patients should know: many common medications — including over-the-counter pain relievers like acetaminophen, cholesterol-lowering statins, and certain antibiotics — can affect liver enzymes. A mildly elevated result may prompt nothing more than a repeat test in a few weeks; a significantly elevated result warrants prompt evaluation. Patients should always tell their physician about all medications, supplements, and herbal products they are taking, because these can all affect liver function test results.

The Thyroid Panel

The thyroid gland regulates metabolism — the rate at which the body uses energy — through the production of thyroid hormones. The thyroid panel measures the hormones involved in this system and is an essential tool for diagnosing thyroid disorders, which are among the most frequently missed conditions in primary care.

The primary marker is TSH — thyroid stimulating hormone — produced by the pituitary gland to signal the thyroid to produce more hormone. TSH and thyroid hormone levels are inversely related: when thyroid hormone is low, TSH rises to stimulate more production; when thyroid hormone is high, TSH falls. This makes TSH an unusually sensitive early indicator of thyroid dysfunction — it often becomes abnormal before the thyroid hormones themselves fall clearly outside the normal range.

An underactive thyroid — hypothyroidism — produces fatigue, weight gain, cold intolerance, depression, constipation, and cognitive slowing. These symptoms overlap substantially with depression, and hypothyroidism is one of the most common conditions misdiagnosed as a psychiatric disorder. An overactive thyroid — hyperthyroidism — produces the opposite pattern: weight loss, anxiety, rapid heart rate, heat intolerance, and tremor.

What patients should know: thyroid testing is not always included in routine bloodwork unless the physician specifically orders it. Patients who are experiencing fatigue, unexplained mood changes, or weight fluctuations without a clear explanation should ask whether their thyroid has been evaluated. A TSH test is inexpensive and straightforward.

The Lipid Panel

The lipid panel measures fats circulating in the bloodstream and is the primary tool for evaluating cardiovascular risk.

Total cholesterol provides an overall picture, but the more clinically meaningful components are LDL cholesterol — often called "bad" cholesterol, because elevated LDL is associated with plaque buildup in arteries — and HDL cholesterol, the "good" cholesterol that helps remove LDL from the bloodstream. Triglycerides, another form of fat measured in the lipid panel, are associated with cardiovascular risk at high levels and often reflect diet, alcohol intake, and metabolic health.

What these numbers mean for any individual patient depends heavily on context. A patient with no other risk factors and an LDL of 130 is in a different position than a patient with diabetes, hypertension, and a family history of early heart disease at the same LDL level. Treatment decisions are based on overall cardiovascular risk — a calculation that incorporates multiple factors — not on any single lipid value.

What patients should know: lipid results are meaningfully affected by what was eaten in the hours before the test. A fasting lipid panel — drawn after at least eight to twelve hours without food — provides more accurate LDL and triglyceride values than a non-fasting draw. Patients should confirm with their physician whether fasting was required for their specific test.

Hemoglobin A1c

The hemoglobin A1c, commonly referred to as A1c or HbA1c, measures average blood sugar levels over the preceding two to three months. It does this by measuring the percentage of hemoglobin — the protein in red blood cells — that has glucose attached to it. Because red blood cells live for approximately three months, the A1c reflects a longer window than a single glucose measurement and is therefore a more reliable indicator of overall blood sugar control.

For patients without diabetes, an A1c below 5.7% is considered normal. Values between 5.7% and 6.4% indicate prediabetes — a state of elevated blood sugar that significantly increases the risk of developing type 2 diabetes and that often responds well to lifestyle interventions. An A1c of 6.5% or above on two separate tests confirms a diagnosis of diabetes.

For patients already diagnosed with diabetes, the A1c is the primary tool for tracking how well blood sugar is being managed over time. Most guidelines target an A1c below 7% for most diabetic patients, though appropriate targets vary depending on the individual's age, other health conditions, and risk tolerance.

What patients should know: the A1c can be falsely elevated or reduced in certain conditions affecting red blood cells, including some anemias and hemoglobin variants. In these patients, the A1c may not accurately reflect blood sugar control, and alternative tests may be more appropriate.

The PSA Test — and Why Context Matters

Prostate-specific antigen, or PSA, is a protein produced by the prostate gland. PSA levels are measured in men to screen for prostate cancer, though the test is imperfect in ways that are important to understand.

PSA can be elevated for reasons other than cancer, including benign prostatic enlargement, prostate inflammation, recent ejaculation, or a digital rectal exam performed shortly before the blood draw. Conversely, some prostate cancers produce relatively low PSA levels. The test is useful, but it requires interpretation in context — a single elevated result is not a diagnosis, and a normal result does not fully exclude cancer.

For men who have been treated for prostate cancer, PSA monitoring is an essential part of follow-up care. After treatment, PSA levels should fall to very low or undetectable levels. A rising PSA in a man who has been treated for prostate cancer is the primary signal of possible recurrence — and it is a signal that must be followed promptly and carefully.

This brings to mind a case that came to Pilot Rock Medical Navigators: a patient with a history of prostate cancer whose bloodwork contained markers consistent with recurrence. The values were present in his records, available to be reviewed. They had not received the attention they warranted. A comprehensive review of his records by the Pilot Rock team identified what had been overlooked and ensured that the appropriate clinical response was set in motion.

What this case illustrates is something that applies beyond PSA to blood work broadly: the value of a result is only realized when it is reviewed carefully, in context, by someone who has the time and the clinical expertise to understand what it means. A number that appears borderline in a brief scan of results may carry significant meaning when examined alongside the patient's history, prior values, and the clinical picture as a whole.

Numbers Need Context — And Trends Matter More Than Single Results

The most important thing to understand about blood work is that no single result should be interpreted in isolation. Reference ranges — the normal windows printed on lab reports — are population-based averages. They describe the range in which approximately 95% of healthy people fall. By definition, 5% of perfectly healthy people will have at least one value outside the normal range on any given panel, simply by statistical chance.

A single abnormal value, particularly a mild one, is often less significant than it appears. It may reflect the timing of the draw, a recent meal or exercise, temporary stress on the body, or simple biological variation. The appropriate response is usually a repeat test or clinical evaluation — not alarm.

Equally important: a result that falls within the normal range is not always reassuring. Normal ranges don't capture every meaningful clinical scenario, and a value that is technically normal for the general population may be abnormal for a specific patient given their baseline, their history, or the trend of their results over time. A PSA that rises from 0.3 to 1.8 over two years, both values technically within normal limits, may be far more significant than the number alone suggests — particularly in a patient with a history of prostate cancer.

Trends over time — the direction in which values are moving across multiple tests — are often more clinically meaningful than any individual result. Patients who want to understand their blood work well should keep track of their results over time and look for patterns, and should ask their physician specifically about any values that are moving in a concerning direction even if they haven't yet crossed outside the normal range.

When Results Raise Questions That Haven't Been Answered

Patients who receive blood work results with values they don't understand, concerns that weren't addressed in a brief follow-up message, or a persistent sense that something in their results deserves more attention are entitled to ask for more.

A specific, direct question — "Can you walk me through what this elevated value means, and what we're watching for?" — will, in most cases, produce a useful answer. Patients should not feel that their results are too complex to understand or that their questions are too basic to ask. Understanding one's own blood work is not a medical privilege. It is a patient's right.

When results are complex, when a history of multiple abnormal findings hasn't produced a clear explanation, or when something in the numbers prompts concern that isn't being adequately addressed, an independent review of the full medical record — including longitudinal lab trends — can identify what may have been missed. That is precisely the kind of review that changed the course of care for the prostate cancer patient whose recurrence was found in bloodwork that had been overlooked.

Blood work is a conversation between the body and the physician. Patients deserve to be part of that conversation.

_____________

If you or a loved one has received blood work results that haven't been fully explained, or if you're concerned that something in your medical history may have been overlooked, Pilot Rock Medical Navigators can help. Book a free 15-minute introductory call to discuss your situation. Learn how Pilot Rock can help →